4th Quarter - Report
DENDREON PHARMACEUTICALS, LLC for DENDREON PHARMACEUTICALS, LLC
Income
—
Expenses
$118,750
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Prostate Cancer treatment and Medicare Part B payment reform. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R. 19 - the Lower Costs, More Cures Act of 2019.
Foreign entity interest: Dendreon, a subsidiary of Nanjing Xinjiekou Department Store, Co. Ltd. in China.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW SAELENS | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| NANJING XINJIEKOU DEPARTMENT STORE, CO. LTD. | China | China | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.